Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Funny the Trixie "tricks" are nowhere to be found now that the stock is sinking like a rock! It will go lower than TMDI before long.
Jasminder's the best! I know it. Just a matter of time. I have so little skin left it's got to count.
Great news! The downside is by time Titan actually begins selling the robot, the early patents will be expiring.
$.70 a share
Less supply cost
A moment ago ADVFN showed the bid at $0.01 so I logged into TD to check level II and noticed there's about twice as many market makers trading TMDI as a year ago. The uplist did this, just interesting to note.
Intuitive would use the suit to drag it out and try to crush Titan with the expense. Bad idea right now.
[Joke about spearhead instrument tip]
...my originality is low right now, so just assume it was a witty joke
Unproven in the market
No...still waiting for momentum on design freeze and approvals. I know the pricing is a good discount now but I believe it will get even better before it goes up.
There's a point where feedback reaches absurdity. 5 surgeons will give you 5 ways one tiny detail should be. Does it work? Good. Produce it and refine it down the road. You will never have a perfect version because every single surgeon has his own definition of the perfect version. Enough is enough, if you want to be stuck in this quagmire ad infinitum, keep getting design feedback. If you want to "commercialize" a robot, commercialize it already damnit!
At some point you've got to say "look doc, here's what you're getting" and move on. Surgeons will "preferencec" you broke. Especially given that's the reason we are not yet to market.
This is good except...
"We believe the care we are taking now to incorporate surgeon feedback into product design...will support a successful product launch."
Isn't this what they've been doing for 8 years? Are they not finishing up or are they still back to the drawing board? Wrap it up TMDI
Got it. Yes it will be a second and I think it will be a slow road but will appreciate in the long run.
In my opinion, their unwillingness to offer price concesions has made the higher cost unpalatable for many hospital systems. Hospitals or doctors surgery centers do not get additional reimbursement for a custom knee component, so the premium is paid by the hospial or doctor, eating controbution margin on the case. In short it's cheaper to use standard components. I think many old school orthopedists are not impressed because computers are a young man's game. I think the newer milllenial orthopedists coming out of residency may be more apt to demand the technology. I know TMDI is a cost savings proposal versus ISRG, so not the same situation but Titan faces the same risk of lack of adoption. TRXC is suffering this but their flaw is endemic and terminal. Titan is a much better propoal than the monster from italy.
I agree with your assessment of the SPORT technology. From this perspective it's really a great all around value proposal. This only holds so much water with the market who demands dividends or growth in order to pay a premium.
Conformis is similar in that it is a new take on an existing procedure; custom made total knee implants, built from scans of the patient to match their anatomy. I'd want that if I were having a total knee replacement. Great technology, wave of the future, been 510k approved and selling for many years, share price is down 97% from 2015 IPO, currently dredging at $0.77.
Obviously not the exact same situation. But I'm trying to highlight that a great technology won't necessarily make you rich without sales growth.
Speaking from my own expectations, when I first heard about Titan in 2015, I got the dollar signs in my eyes because it was to be the next ISRG and I'd soon make a lot from the discounted price. It's clear we have a long way to go, and we are not the next ISRG (nor is anyone - kind of like there is no "the next beatles" like everyone likes to claim about their new favorite band). However, SPORT has a good market niche opportunity in ASCs in North America . If it focuses on that first, I believe it will do well because no ASC currently has a robot and at a good price point there could be strong demand. Additionally, Europe, South America and Asia present opportunities - many of the nations are not well penetrated by ISRG. So a lower cost option may be attractive to even larger systems.
Willie im not sure I understand the question - how many what? Units sold?
Thanks for your level headed analysis. As usual, you are a class act Flendy.
Design freeze, fda, ce approvals should all be a boon to market cap. I'm skeptical they can retain share price growth. It seems only consistent net income growth can bolster sp growth. But who knows optimism could drive sp up. I'm just thinking of conformis...sp should be sky high, the next thing in a huge market but anemic sales have made it a deep discount stock. Just shows how 510k is not necessarily panacea.
It would be $0.33 to $0.5 pre RS
Totally agree. The capacity to offer the same MIS procedure at a lower cost (relative to davinci use not traditional lap) with a barely noticeable umbilicus scar is a real slam dunk for patients
I don't think you understand the "drank the coolaid" expression. It's not about running out lol
Heh heh ... 2014trader start polishing your crow carver
Good question...who the hell knows what they're cooking up?
ISRG has always been a shark so there's no reason to expect that to change. My theory is while SPORT will be the only foreseeable single port competitor, SPORT's sell to administrators and physicians of acyte care facilites will be tough because they can just upgrade their Xi and not have 2x the capital, service, disposables and inventory management overhead expense. But since Xis are not likely to be sold ever to a small outpatient surg center, sport can leverage that niche.
Or...if SPORT gets indication for any GI lab minor procedures, I could see the case for having one alongside the SP, because it would fit the department. Point being with larger systems having the option to augment their existing system with SP or adopt a whole seperate system...the later would be very costly. This is of course assuming SP is indicated for the same procedures as SPORT. If not its a whole different ballgame.
The SP means SPORT's innovation angle jig is up. They missed the boat with years of delays. However, they can still hold the mantle for a market niche - ambulatory robotic surgery. If I'm being realistic, the opportunity in large systems is diminished - most would rather keep one system/manufacturer for supply chain efficiency's sake. But no smaller ambulatory surgery center is going to pick the monstrous SP over the sleeker more cost effective SPORT.
The way I see it, ISRG will horizontally integrate every new robot competitor that doesn't flop on its own within 5 years of sales commencement. TMDI owners will get a sweet buyout deal and TRXC owners will still be butthurt from losing their investment.
SP doesnt have true snake arms and has the clunky 3rd arm in the way. And let's not forget SPORT'S windshield wiper. No matter what SPORT will always have the cost advantage - that's worth something.
Turd Poop is a scam artist. He will be "Ruth" to some dude named Chris in prison - only beef he's getting.
What milestones has he missed? Last report they were ahead on deliverables
We have a disagreement on the future, and I think you are patronizing but I enjoy your sense of humor sir.
Make your money now but Trixie is a long term loser. No real value in the technology. The eye sensing tech is neat, maybe the only worthwhile part. Haptic feedback is uneccesary and lawsuit city for TRXC. 4 towers is a JOKE and a step BACKWARD from DaVinci. Sales are sluggish - not a better proposition over DaVinci to surgeons and administrators. Sorry, Charles.
Or should i say TURD Poop
That's why he's Todd Poop
Where's your windshield wiper, SP?!
If we had the answer there would be no need for this forum
Best part of the release...q filings 1 year ahead of schedule...
"Filed three Q-submissions containing detailed protocols for animal, cadaver and human confirmatory studies for review by the U.S. Food and Drug Administration ("FDA"), approximately one year ahead of plan"
Encouraging that my suspicion that Mac is ahead of his stated milestones is correct. May submit for 510 mid 2019 rather than end?
Got a link slick?
Whats a MAGA driver? Are you referring to the president?